16 Recruiting Advanced or Metastatic Solid Tumors Phase 1 Clinical Trials
Active phase 1 studies for advanced or metastatic solid tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced or Metastatic Solid Tumors studiesPhase 1 Studies for Advanced or Metastatic Solid Tumors
A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)
📍 Sanford Cancer Center ( Site 0005) — Sioux Falls, South Dakota
View Study & Checklist ➔A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
📍 Sarah Cannon Research Institute (HealthONE) — Denver, Colorado
View Study & Checklist ➔A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
📍 Massachusetts General Hospital - Boston — Boston, Massachusetts
View Study & Checklist ➔A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
📍 University of Southern California (USC) — Los Angeles, California
View Study & Checklist ➔A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
📍 HonorHealth Research Institute — Phoenix, Arizona
View Study & Checklist ➔A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
📍 Site: 001-058 — New Haven, Connecticut
View Study & Checklist ➔DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
📍 UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica) — Santa Monica, California
View Study & Checklist ➔A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔